Bimeda News

Bimeda Launches First Annual Sustainability Report

Bimeda is pleased to announce the launch of the company's first Annual Sustainability Report. The report is now available to read and download on onebimeda.com In early 2022, Bimeda announced the launch of its sustainability strategy, centred around ...

Bimeda® Announces Sponsorship of Hagyard Equine Medical Institute’s new Podcast The Spirit of Hagyard

Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...

Bimeda Appoints CFO, Adam Reizer

Bimeda Inc is pleased to announce the appointment of Adam Reizer as the Chief Financial Officer for Bimeda North America. Adam reports to Gavin Tierney, CEO. Adam was born and raised in Chicago, IL. H...

Bimeda Acquires Afrivet

Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...

Bimeda Launches Sustainability-Focused Website, onebimeda.com

Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...

Bimeda Welcomes Samuel Cossio

Bimeda is pleased to announce the appointment of Samuel Cossio as Territory Sales Manager for the states of Idaho, Oregon, and Washington. Sam will be part of the livestock sales team and assist in th...

Bimeda® Announces First Generic Ketoprofen Injection for Horses, Ketomed™

Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...

Bimeda® Announces Re-introduction of Ovacyst® and Prostamate®

Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...

Bimeda® Announces First Ever FDA-approved Generic Detomidine Hydrochloride Injection

Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...

PROMOTION ANNOUNCEMENT: Dr. Dave Ellefson

It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...

Technical Services Veterinarian, Dr. Chris Thomsen

Bimeda is pleased to announce the addition of Dr. Chris Thomsen in the role of field based Technical Services Veterinarian, with a focus on beef cattle. Dr. Thomsen will also assist with Equine Techni...